The dysregulation of the PI3K/AKT pathway has been demonstrated in different solid tumors including breast cancer, and it has been suggested that this dysregulation is associated with the increased mutations in pathway genes PIK3CA and AKT1 [36, 39]. The gene discussed is AKT1; the disease is breast cancer.